0K3W.LSE Myriad Genetics Inc.

Healthcare Oil, Gas & Consumable Fuels London Exchange
- USD
Market cap
-
P/E
-
P/B
-
ROE
-50.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 0K3W.LSE undervalued?

Graham number

The Graham number of Myriad Genetics Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Myriad Genetics Inc. fundamental analysis

No fundamental analysis for Myriad Genetics Inc. yet.

Myriad Genetics Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Myriad Genetics Inc.

Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. It offers molecular diagnostic tests for oncology, women's health, and pharmacogenomics. It provides MyRisk Hereditary Cancer test, a DNA sequencing test for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic test, a DNA sequencing test for metastatic breast, ovarian, metastatic pancreatic, and metastatic prostate cancer with deleterious or suspected delet…

Full company profile